Pharmacokinetic/Pharmacodynamic (PK/PD) modeling is a quantitative approach used to characterize the relationship between drug exposure and biological response. It integrates pharmacokinetic data with pharmacodynamic endpoints to establish a quantitative link between dose and effect. PK/PD modeling provides a data-driven framework for evaluating efficacy, safety, and variability in drug response.
PK/PD modeling helps optimize dose and regimen selection, improve the therapeutic window, de-risk development, and inform confident clinical and regulatory decision-making by providing a clear exposure-response understanding across development stages.
Key Questions PK/PD Modeling Can Answer
- What level of exposure is required to achieve meaningful clinical efficacy?
- What is the quantitative relationship between exposure and response?
- Where is the therapeutic window balancing efficacy and safety?
- How does patient variability influence dose-response and dosing strategy?
- Which dosing regimen is most likely to maximize benefit and minimize risk?
Case Studies
Mechanistic translational (PK/RO) model to predict FIH dose and SUD regimen for T-cell engager
Cis‑Binding & Valency Modeling of CTX8371
Semi-mechanistic PK/PD modeling of anti-CD47 therapeutic agent
